BOIRF
Price
$24.50
Change
+$0.20 (+0.82%)
Updated
Aug 29 closing price
Capitalization
580.46M
ELAN
Price
$19.14
Change
+$0.22 (+1.16%)
Updated
Sep 26, 10:52 AM (EDT)
Capitalization
9.4B
46 days until earnings call
Interact to see
Advertisement

BOIRF vs ELAN

Header iconBOIRF vs ELAN Comparison
Open Charts BOIRF vs ELANBanner chart's image
Boiron
Price$24.50
Change+$0.20 (+0.82%)
Volume$800
Capitalization580.46M
Elanco Animal Health
Price$19.14
Change+$0.22 (+1.16%)
Volume$1.41K
Capitalization9.4B
BOIRF vs ELAN Comparison Chart in %
Loading...
BOIRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BOIRF vs. ELAN commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOIRF is a Buy and ELAN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (BOIRF: $24.50 vs. ELAN: $18.92)
Brand notoriety: BOIRF: Not notable vs. ELAN: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BOIRF: 169% vs. ELAN: 50%
Market capitalization -- BOIRF: $580.46M vs. ELAN: $9.4B
BOIRF [@Pharmaceuticals: Generic] is valued at $580.46M. ELAN’s [@Pharmaceuticals: Generic] market capitalization is $9.4B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOIRF’s FA Score shows that 1 FA rating(s) are green whileELAN’s FA Score has 0 green FA rating(s).

  • BOIRF’s FA Score: 1 green, 4 red.
  • ELAN’s FA Score: 0 green, 5 red.
According to our system of comparison, BOIRF is a better buy in the long-term than ELAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOIRF’s TA Score shows that 4 TA indicator(s) are bullish while ELAN’s TA Score has 3 bullish TA indicator(s).

  • BOIRF’s TA Score: 4 bullish, 0 bearish.
  • ELAN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BOIRF is a better buy in the short-term than ELAN.

Price Growth

BOIRF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while ELAN (@Pharmaceuticals: Generic) price change was -0.94% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.88%. For the same industry, the average monthly price growth was +23.85%, and the average quarterly price growth was +67.10%.

Reported Earning Dates

ELAN is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.88% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELAN($9.4B) has a higher market cap than BOIRF($580M). ELAN has higher P/E ratio than BOIRF: ELAN (21.50) vs BOIRF (18.68). ELAN YTD gains are higher at: 56.235 vs. BOIRF (-14.035).
BOIRFELANBOIRF / ELAN
Capitalization580M9.4B6%
EBITDAN/A1.45B-
Gain YTD-14.03556.235-25%
P/E Ratio18.6821.5087%
RevenueN/A4.48B-
Total CashN/A539M-
Total DebtN/A4.21B-
FUNDAMENTALS RATINGS
BOIRF vs ELAN: Fundamental Ratings
BOIRF
ELAN
OUTLOOK RATING
1..100
4557
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
93
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7079
PRICE GROWTH RATING
1..100
6440
P/E GROWTH RATING
1..100
7488
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BOIRF's Valuation (7) in the null industry is significantly better than the same rating for ELAN (93) in the Agricultural Commodities Or Milling industry. This means that BOIRF’s stock grew significantly faster than ELAN’s over the last 12 months.

BOIRF's Profit vs Risk Rating (100) in the null industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that BOIRF’s stock grew similarly to ELAN’s over the last 12 months.

BOIRF's SMR Rating (70) in the null industry is in the same range as ELAN (79) in the Agricultural Commodities Or Milling industry. This means that BOIRF’s stock grew similarly to ELAN’s over the last 12 months.

ELAN's Price Growth Rating (40) in the Agricultural Commodities Or Milling industry is in the same range as BOIRF (64) in the null industry. This means that ELAN’s stock grew similarly to BOIRF’s over the last 12 months.

BOIRF's P/E Growth Rating (74) in the null industry is in the same range as ELAN (88) in the Agricultural Commodities Or Milling industry. This means that BOIRF’s stock grew similarly to ELAN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BOIRFELAN
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
15%
Bearish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 5 days ago
12%
Bullish Trend 1 day ago
59%
MACD
ODDS (%)
Bullish Trend 1 day ago
7%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
10%
Bearish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
10%
Bullish Trend 1 day ago
66%
Advances
ODDS (%)
N/A
Bullish Trend 1 day ago
63%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
73%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
18%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
BOIRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ASPCX28.56N/A
N/A
Alger Spectra C
VTPSX156.63N/A
N/A
Vanguard Total Intl Stock Idx InstlPls
RLIEX19.95N/A
N/A
Lazard International Equity R6
TAGDX16.74N/A
N/A
Transamerica Large Growth R6
AMAHX10.20N/A
N/A
American Century Small Cap Dividend A

BOIRF and

Correlation & Price change

A.I.dvisor tells us that BOIRF and ELAN have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BOIRF and ELAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOIRF
1D Price
Change %
BOIRF100%
N/A
ELAN - BOIRF
21%
Poorly correlated
+0.91%
BUDZ - BOIRF
7%
Poorly correlated
-3.23%
BSPK - BOIRF
4%
Poorly correlated
-6.90%
APNHY - BOIRF
3%
Poorly correlated
-6.64%
BIOVF - BOIRF
1%
Poorly correlated
N/A
More